Cimetidine as modulator of the cell‐mediated immune response in vivo using the tuberculin skin test as parameter.
- 1 February 1990
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 29 (2) , 257-260
- https://doi.org/10.1111/j.1365-2125.1990.tb03630.x
Abstract
The in vivo pharmacological effects of cimetidine on delayed hypersensitivity reactions in healthy volunteers were studied using the tuberculin skin test as parameter. Cimetidine clearly enhanced this reaction when it was administered well before antigenic stimulation.This publication has 16 references indexed in Scilit:
- EFFECT OF CIMETIDINE ON SURVIVAL AFTER GASTRIC CANCERThe Lancet, 1988
- Treatment of Reflux Oesophagitis with H2-Receptor AntagonistsScandinavian Journal of Gastroenterology, 1988
- Immunomodulating Drugs Increase Resistance against Sepsis in Traumatized MicePublished by Wolters Kluwer Health ,1986
- Bacille Calmette-Guérin Vaccinations and Tuberculin Skin TestsJAMA, 1985
- Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells.Journal of Clinical Investigation, 1985
- Modulation of Suppressor-Cell Activity by Cimetidine in Patients with Common Variable HypogammaglobulinemiaNew England Journal of Medicine, 1985
- Autacoids as modulators of the inflammatory and immune responseThe American Journal of Medicine, 1981
- CIMETIDINE REDUCTION OF TUMOUR FORMATION IN MICEThe Lancet, 1981
- EFFECT OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON DELAYED HYPERSENSITIVITYThe Lancet, 1978